ACELYRIN (SLRN)
About
Business overview of ACELYRIN (SLRN)
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.
Key Insights
Critical company metrics and information
Share Price
$2.14Market Cap
$214.70 MillionTotal Outstanding Shares
100.33 Million SharesTotal Employees
130Dividend
No dividendIPO Date
May 5, 2023SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQType
Common StockPhone Number
805-871-4300Address
4149 liberty canyon rd., Agoura hills, CA, 91301Homepage
https://www.acelyrin.com
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $165.87 Million |
| Net Cash Flow From Financing Activities, Continuing | $1.01 Million |
| Net Cash Flow, Continuing | $88.12 Million |
| Net Cash Flow From Financing Activities | $1.01 Million |
| Net Cash Flow From Investing Activities, Continuing | $165.87 Million |
| Net Cash Flow From Operating Activities | $-78.76 Million |
Income Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Income/Loss From Continuing Operations After Tax | $-48.55 Million |
| Operating Income/Loss | $-54.75 Million |
| Net Income/Loss | $-48.55 Million |
| Operating Expenses | $54.75 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Accounts Payable | $17.55 Million |
| Assets | $618.31 Million |
| Liabilities | $90.03 Million |
| Equity | $528.28 Million |
| Other Non-current Assets | $20.02 Million |
| Liabilities And Equity | $618.31 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2025 Financhle. All Rights Reserved.